The global Intravenous Immunoglobulin (IVIG) Market, which was valued at USD 11.2 billion in 2021, is poised for significant growth. With an estimated compound annual growth rate (CAGR) of 7.3% from 2022 to 2031, the market is expected to reach USD 20.5 billion by the end of the forecast period. The growing demand for immunotherapy treatments and t